Kato H - Search Results

1

Prospective Clinical Evaluation of the Diagnostic Accuracy of a Highly Sensitive Rapid Antigen Test Using Silver Amplification Technology for Emerging SARS-CoV-2 Variants.

Obata K, Miyakawa K, Takei T, Wada A, Hatayama Y, Kato H, Kimura Y, Sekino H, Katada J, Ryo A. Obata K, et al. Among authors: kato h. Biomedicines. 2022 Nov 3;10(11):2801. doi: 10.3390/biomedicines10112801. Biomedicines. 2022. PMID: 36359321 Free PMC article.

2

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors.

Goto A, Go H, Miyakawa K, Yamaoka Y, Ohtake N, Kubo S, Jeremiah SS, Mihara T, Senuki K, Miyazaki T, Ikeda S, Ogura T, Kato H, Matsuba I, Sanno N, Miyakawa M, Ozaki H, Kikuoka M, Ohashi Y, Ryo A, Yamanaka T. Goto A, et al. Among authors: kato h. Front Microbiol. 2021 May 7;12:661187. doi: 10.3389/fmicb.2021.661187. eCollection 2021. Front Microbiol. 2021. PMID: 34025615 Free PMC article.

3

Evaluation of a combination protocol of CT-first triage and active telemedicine methods by a selected team tackling COVID-19: An experimental research study.

Miyake S, Higurashi T, Kato H, Yamaoka Y, Kessoku T, Kato S, Ogawa F, Oi Y, Nakajima A, Yamamoto T, Takeuchi I, Ryo A, Maeda S. Miyake S, et al. Among authors: kato s, kato h. J Infect Public Health. 2021 Sep;14(9):1212-1217. doi: 10.1016/j.jiph.2021.08.016. Epub 2021 Aug 18. J Infect Public Health. 2021. PMID: 34425358 Free PMC article.

4

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera.

Miyakawa K, Jeremiah SS, Kato H, Yamaoka Y, Go H, Yajima S, Shimada T, Mihara T, Goto A, Yamanaka T, Ryo A. Miyakawa K, et al. Among authors: kato h. J Mol Cell Biol. 2022 Jan 29;13(12):918-920. doi: 10.1093/jmcb/mjab050. J Mol Cell Biol. 2022. PMID: 34450642 Free PMC article. No abstract available.

5

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay.

Kato H, Miyakawa K, Ohtake N, Go H, Yamaoka Y, Yajima S, Shimada T, Goto A, Nakajima H, Ryo A. Kato H, et al. J Infect Chemother. 2022 Feb;28(2):273-278. doi: 10.1016/j.jiac.2021.11.021. Epub 2021 Nov 29. J Infect Chemother. 2022. PMID: 34857462 Free PMC article.

6

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection.

Miyakawa K, Kubo S, Stanleyraj Jeremiah S, Go H, Yamaoka Y, Ohtake N, Kato H, Ikeda S, Mihara T, Matsuba I, Sanno N, Miyakawa M, Shinkai M, Miyazaki T, Ogura T, Ito S, Kaneko T, Yamamoto K, Goto A, Ryo A. Miyakawa K, et al. Among authors: kato h. Open Forum Infect Dis. 2021 Dec 10;9(2):ofab626. doi: 10.1093/ofid/ofab626. eCollection 2022 Feb. Open Forum Infect Dis. 2021. PMID: 35071683 Free PMC article.

7

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2.

Miyakawa K, Jeremiah SS, Yamaoka Y, Koyama T, Tokumasu R, Kudo M, Kato H, Ryo A. Miyakawa K, et al. Among authors: kato h. Front Med (Lausanne). 2022 Feb 10;9:811004. doi: 10.3389/fmed.2022.811004. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35223905 Free PMC article.

8

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination.

Kato H, Miyakawa K, Ohtake N, Yamaoka Y, Yajima S, Yamazaki E, Shimada T, Goto A, Nakajima H, Ryo A. Kato H, et al. Vaccine. 2022 Apr 26;40(19):2652-2655. doi: 10.1016/j.vaccine.2022.03.057. Epub 2022 Mar 29. Vaccine. 2022. PMID: 35370020 Free PMC article.

9

Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System.

Yamaoka Y, Jeremiah SS, Funabashi R, Miyakawa K, Morita T, Mihana Y, Kato H, Ryo A. Yamaoka Y, et al. Among authors: kato h. Viruses. 2022 Jul 1;14(7):1461. doi: 10.3390/v14071461. Viruses. 2022. PMID: 35891441 Free PMC article.

10

Enhancement of Humoral and Cellular Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 by a Third Dose of BNT162b2 Vaccine in Japanese Healthcare Workers.

Miyakawa K, Kato H, Ohtake N, Jeremiah SS, Ryo A. Miyakawa K, et al. Among authors: kato h. J Infect Dis. 2023 Jan 11;227(2):221-225. doi: 10.1093/infdis/jiac344. J Infect Dis. 2023. PMID: 35978486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,992 results

Search Page